VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 19 filers reported holding VERONA PHARMA PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 3.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $64,214,475 | +155.9% | 2,457,500 | 0.0% | 20.92% | +143.9% |
| Q3 2022 | $25,091,000 | +146.6% | 2,457,500 | 0.0% | 8.58% | +163.4% |
| Q2 2022 | $10,174,000 | -16.2% | 2,457,500 | +0.0% | 3.26% | -5.4% |
| Q1 2022 | $12,140,000 | -25.6% | 2,457,499 | 0.0% | 3.44% | -12.9% |
| Q4 2021 | $16,318,000 | +21.8% | 2,457,499 | 0.0% | 3.95% | +30.1% |
| Q3 2021 | $13,393,000 | -16.3% | 2,457,499 | 0.0% | 3.04% | -38.5% |
| Q2 2021 | $15,998,000 | -21.1% | 2,457,499 | 0.0% | 4.94% | -29.4% |
| Q1 2021 | $20,274,000 | +19.7% | 2,457,499 | 0.0% | 7.00% | +20.9% |
| Q4 2020 | $16,932,000 | +10.4% | 2,457,499 | 0.0% | 5.79% | +76.6% |
| Q3 2020 | $15,335,000 | +263.3% | 2,457,499 | +172.5% | 3.28% | +178.0% |
| Q2 2020 | $4,221,000 | +13.6% | 901,943 | 0.0% | 1.18% | -52.2% |
| Q1 2020 | $3,716,000 | -29.0% | 901,943 | 0.0% | 2.47% | -2.4% |
| Q4 2019 | $5,231,000 | +26.9% | 901,943 | 0.0% | 2.53% | -3.0% |
| Q3 2019 | $4,122,000 | -9.1% | 901,943 | 0.0% | 2.61% | +49.8% |
| Q2 2019 | $4,537,000 | -17.5% | 901,943 | 0.0% | 1.74% | -64.7% |
| Q1 2019 | $5,502,000 | -32.2% | 901,943 | 0.0% | 4.92% | -33.2% |
| Q4 2018 | $8,117,000 | -28.0% | 901,943 | 0.0% | 7.38% | +10.0% |
| Q3 2018 | $11,274,000 | – | 901,943 | – | 6.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |